等待開盤 08-09 09:30:00 美东时间
+4.030
+1.33%
Wells Fargo analyst Lawrence Biegelsen maintains Insulet (NASDAQ:PODD) with a Overweight and raises the price target from $330 to $350.
08-08 23:08
U.S. stocks were mixed, with the Dow Jones index falling around 200 points on T...
08-07 23:08
Makers of insulin delivery systems, Tandem Diabetes Care (NASDAQ:TNDM) and Insulet (NASDAQ:PODD), marked a contrasting stock performance on Thursday as Wall Street reacted to their Q2 2025 results, wh...
08-07 22:04
Insulet (NASDAQ:PODD) lowers FY2025 sales outlook from $2.49 billion-$2.55 billion to $2.45 billion-$2.52 billion vs $2.53 billion estimate.
08-07 19:25
Insulet (NASDAQ:PODD) sees Q3 sales of $663.558 million-$679.875 million vs $645.86 million analyst estimate.
08-07 19:16
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Insulet (NASDAQ:PODD) has outperformed the market over the past 10 years by 12....
08-02 04:45
Insulet's (NYSE:PODD) short percent of float has risen 16.26% since its last re...
07-23 03:00
Insulet (NASDAQ:PODD) has outperformed the market over the past 10 years by 12....
07-18 07:45
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
07-14 19:40